Trial intelligence / Profile preview

Daily interruption of sedation in mechanically ventilated critically ill children

NL-OMON25319Recruiting

Sponsor
Erasmus MC
Start
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of midazolam and morphine in critical illness (2 arms), sponsored by Erasmus MC. Primary endpoint: Ventilator-free days at 28 days. Started Oct 2009; status: recruiting.

02

Drugs

midazolammorphine
03

Conditions

critical illness

Beyond the preview

Go deeper on NL-OMON25319.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25319.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call